JAZZ vs ORN · P/E 1988, rev $2.28B vs P/E 69, rev $852.3M
Jazz Pharmaceuticals PLC (JAZZ) versus Orion Group Holdings Inc (ORN) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Orion Group Holdings Inc (ORN) is a engineering & construction company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported ORN revenue for 2025-12-31 was $852.3M. Net income was $2.5M. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. ORN currently screens at market cap $618.5M and trailing P/E 69.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. ORN currently screens at market cap $618.5M and trailing P/E 69.5.
Not investment advice. Open the JAZZ and ORN stock pages for the full models.
Not investment advice.